Surgical Bypass versus Endoscopic Stenting for Unresectable Head Pancreatic Cancer, Which Palliative Treatment Is Better in Developing Countries, Morocco as an Example
- 1 Department of Visceral Surgery, Faculty of Medicine and Pharmacy of Fez, University Hospital Hassan II—Fes, Sidi Mohamed Ben Abdellah University, Fez, Morocco
- 2 Department of Visceral Surgery, Faculty of Medicine and Pharmacy of Fez, University Hospital Hassan II—Fes, Sidi Mohamed Ben Abdellah University, Fez, Morocco
- 3 Department of Visceral Surgery, Faculty of Medicine and Pharmacy of Fez, University Hospital Hassan II—Fes, Sidi Mohamed Ben Abdellah University, Fez, Morocco
- 4 Department of Visceral Surgery, Faculty of Medicine and Pharmacy of Fez, University Hospital Hassan II—Fes, Sidi Mohamed Ben Abdellah University, Fez, Morocco
- 5 Department of Visceral Surgery, Faculty of Medicine and Pharmacy of Fez, University Hospital Hassan II—Fes, Sidi Mohamed Ben Abdellah University, Fez, Morocco
- 6 Department of Visceral Surgery, Faculty of Medicine and Pharmacy of Fez, University Hospital Hassan II—Fes, Sidi Mohamed Ben Abdellah University, Fez, Morocco
- 7 Department of Visceral Surgery, Faculty of Medicine and Pharmacy of Fez, University Hospital Hassan II—Fes, Sidi Mohamed Ben Abdellah University, Fez, Morocco
- 8 Department of Visceral Surgery, Faculty of Medicine and Pharmacy of Fez, University Hospital Hassan II—Fes, Sidi Mohamed Ben Abdellah University, Fez, Morocco
- 9 Department of Visceral Surgery, Faculty of Medicine and Pharmacy of Fez, University Hospital Hassan II—Fes, Sidi Mohamed Ben Abdellah University, Fez, Morocco
Abstract
Background: Metal stents for unresectable pancreatic cancer are associated with longer patency and superior cost-effectiveness. However, they are too expensive to be recommended routinely in developing countries. Moreover, a debate on outcome results in these patients who receive plastic biliary endoprothesis versus surgical bypass as palliation of obstructive jaundice. We aimed to compare retrospectively the outcomes in patients treated with plastic stent or surgical bypass as a palliative option for these patients. Patients and Methods: We have examined data for patients (n = 86) who received endoscopic stenting (n = 64) or surgical bypass (n = 22), from January 2013 to November 2016, as a palliative treatment for obstructive jaundice from inoperable cancer head pancreas. Results: Serum bilirubin and CA19.9 levels were comparable in age and gender matched patient groups. Moreover, post-operative major complications and 30-days mortality showed no significant differences among patient groups. However, surgical bypass treated patients showed longer initial hospital stay (9 vs. 6 days, p = 0.014), higher cost ($1600 vs. $1088) and longer survival (192 vs. 101 days, p = 0.003) compared to endoscopy-stenting treated patients. Re-hospitalization was required for 5 stented patients (averaged $448). Conclusion: Biliary bypass surgery for unresectable pancreatic cancer may improve patient survival, although prolongs hospital stay. It may be recommended for relatively fit patients with a life expectancy of 6 months and more.
- Luttges, J. and Kloppel, G. (2005) Pancreatic Ductal Adenocarcinoma and Its Precursors. Der Pathologe, 26, 12-17.
- Tempero, M.A., Arnoletti, J.P., Behrman, S.W., Ben-Josef, E., Benson, A.B., Casper, E.S., Cohen, S.J., Czito, B., Ellenhorn, J.D., Hawkins, W.G., et al. (2012) Pancreatic Adenocarcinoma, Version 2.2012: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network, 10, 703-713. https://doi.org/10.6004/jnccn.2012.0073
- Distler, M., Kersting, S., Ruckert, F., Dobrowolski, F., Miehlke, S., Grutzmann, R. and Saeger, H.D. (2010) Palliative Treatment of Obstructive Jaundice in Patients with Carcinoma of the Pancreatic Head or Distal Biliary Tree. Endoscopic Stent Placement vs. Hepaticojejunostomy. Journal of the Pancreas, 11, 568-574.
- Smith, A.C., Dowsett, J.F., Russell, R.C., Hatfield, A.R. and Cotton, P.B. (1994) Randomised Trial of Endoscopic Stenting versus Surgical Bypass in Malignant Low Bileduct Obstruction. The Lancet, 344, 1655-1660.
- Maosheng, D., Ohtsuka, T., Ohuchida, J., Inoue, K., Yokohata, K., Yamaguchi, K., Chijiiwa, K. and Tanaka, M. (2001) Surgical Bypass versus Metallic Stent for Unresectable Pancreatic Cancer. Journal of Hepato-Biliary-Pancreatic Surgery, 8, 367-373. https://doi.org/10.1007/s005340170010
- Santagati, A., Ceci, V., Donatelli, G., Pasqualini, M.J., Silvestri, F., Pitasi, F., Sportelli, G. and Fiocca, F. (2003) Palliative Treatment for Malignant Jaundice: Endoscopic vs. Surgical Approach. European Review for Medical and Pharmacological Sciences, 7, 175-180.
- Scott, E.N., Garcea, G., Doucas, H., Steward, W.P., Dennison, A.R. and Berry, D.P. (2009) Surgical Bypass vs. Endoscopic Stenting for Pancreatic Ductal Adenocarcinoma. HPB: The Official Journal of the International Hepato Pancreato Biliary Association, 11, 118-124. https://doi.org/10.1111/j.1477-2574.2008.00015.x
- Raikar, G.V., Melin, M.M., Ress, A., Lettieri, S.Z., Poterucha, J.J., Nagorney, D.M. and Donohue, J.H. (1996) Cost-Effective Analysis of Surgical Palliation versus Endoscopic Stenting in the Management of Unresectable Pancreatic Cancer. Annals of Surgical Oncology, 3, 470-475. https://doi.org/10.1007/BF02305765
- Yeoh, K.G., Zimmerman, M.J., Cunningham, J.T. and Cotton, P.B. (1999) Comparative Costs of Metal versus Plastic Biliary Stent Strategies for Malignant Obstructive Jaundice by Decision Analysis. Gastrointestinal Endoscopy, 49, 466-471.
- Warshaw, A.L. and Fernandez-del Castillo, C. (1992) Pancreatic Carcinoma. The New England Journal of Medicine, 326, 455-465. https://doi.org/10.1056/NEJM199202133260706